MarketPeel
Insider Trading Intelligence
BA

Behzad Aghazadeh

WHWK
DIRECTOR · WHITEHAWK THERAPEUTICS, INC. · CIK 0001701815
FILING MIX · LIFETIME100%/0%
BUYS
7
SELLS
0
TOTAL VALUE
$61.26M
COMPANIES
2
ACTIVE SINCE
Jun 2025
HOLDINGS NOW
3,126,928
AVG SELL PX
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Behzad Aghazadeh. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
WHWK · 38,040 shares · as of Jun 12, 2026
03,677,6797,355,35711,033,03614,710,7142026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2026
2026
2026
FLOW · 7 buys / 0 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SCTX
SCRIBE THERAPEUTICS, INC.
PURCHASE
7,905$18.25$144.3K3,088,888Jul 28, 2026Jul 28, 2026View →
SCTX
SCRIBE THERAPEUTICS, INC.
PURCHASE
2,333,333$15.00$35.00M3,030,983Jul 24, 2026Jul 28, 2026View →
SCTX
SCRIBE THERAPEUTICS, INC.
PURCHASE
50,000$22.31$1.12M3,080,983Jul 24, 2026Jul 28, 2026View →
SCTX
SCRIBE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,72514,725Jul 23, 2026Jul 27, 2026View →
WHWK
WHITEHAWK THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
38,04038,040Jun 12, 2026Jun 15, 2026View →
WHWK
WHITEHAWK THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,377,714$3.92$25.00M14,710,714May 12, 2026May 14, 2026View →
WHWK
WHITEHAWK THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00640,006Jun 12, 2025Jun 16, 2025View →
Other insiders · WHWK
Loading peer insiders…
About this filer
CIK 0001701815
ROLE
Director
PRIMARY
WHWK
COMPANIES
2
ACTIVE SINCE
Jun 2025
MARKETPEEL · /INSIDER/0001701815DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback